中年炎症标志物与10年随访时认知表现的关联
基于芬兰全国性健康2000调查及其2011随访的前瞻性队列研究,纳入915名45-74岁参与者,评估中年白介素-6(IL-6)、肿瘤坏死因子α(TNF-α)和高敏C反应蛋白(hs-CRP)与10年后认知表现的关系。结果显示基线IL-6和TNF-α较高预测10年随访时词语流畅性和单词列表学习表现较差,IL-6升高还预测词语流畅性和单词列表学习下降更大;hs-CRP无预测作用。
要点
- 中年IL-6和TNF-α较高与10年后词语流畅性和单词列表学习表现较差相关。
- 中年IL-6升高预测10年后词语流畅性和单词列表学习下降更大。
- 基线TNF-α不预测认知下降,hs-CRP不预测10年后认知表现或下降。
核心结论
- 中年低度炎症似乎是晚年认知表现较差的独立危险因素。
- 在所研究的标志物中,IL-6和TNF-α对认知表现和下降的预测似乎强于hs-CRP。
研究设计与样本
- 前瞻性队列研究,基于芬兰全国性、基于人群的健康2000检查调查、2000-2001年补充检查及2011年健康随访调查。
- 共纳入915名45-74岁参与者(中位年龄54岁,55%为女性)。
- 基线低度炎症于2001年以IL-6、TNF-α和hs-CRP测量。
- 基线及随访时认知表现以分类词语流畅性(VF)、单词列表学习(WLL)和单词列表延迟回忆(WLDR)评估。
- 采用多变量线性模型分析,校正年龄、性别、教育、APOE ε4基因型、2型糖尿病、高血压、高胆固醇血症、体重指数、抑郁症状、吸烟和基线认知。
主要发现
- 基线IL-6较高预测10年随访时词语流畅性表现较差(β:-1.14,p=0.003)和单词列表学习表现较差(β:-0.61,p=0.007)。
- 基线TNF-α较高预测10年随访时词语流畅性表现较差(β:-1.78,p=0.008)和单词列表学习表现较差(β:-0.86,p=0.03)。
- IL-6升高预测10年随访后词语流畅性下降更大(β:-0.81,p=0.01)和单词列表学习下降更大(β:-0.53,p=0.008)。
- 基线TNF-α不预测认知下降。
- hs-CRP不预测10年后认知表现或下降。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Chronic low-grade inflammation, commonly associated with cardiovascular diseases and risk factors, has been associated inconclusively with cognitive decline and dementia. The aim of our study was to evaluate whether low-grade inflammation, measured in midlife, is associated with a decline in cognitive performance after a 10-year follow-up. We hypothesized that low-grade inflammation, estimated by interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and high-sensitivity CRP (hs-CRP), is a predictor of cognitive decline in the general population. METHODS: This prospective cohort study is based on a Finnish nationwide, population-based Health 2000 Examination Survey, its supplemental examinations in 2000-2001, and the follow-up Health 2011 Survey. Cognitive performance at baseline and at follow-up was assessed with categorical verbal fluency (VF), word-list learning (WLL), and word-list delayed recall (WLDR). Baseline low-grade inflammation was measured with IL-6, TNF-α, and hs-CRP in 2001. Associations between low-grade inflammation and cognitive performance were analyzed with multivariable linear models adjusted for age, sex, education, APOE ε4 genotype, type 2 diabetes, hypertension, hypercholesterolemia, body mass index, depressive symptoms, smoking, and baseline cognition. RESULTS: Nine hundred fifteen participants aged 45-74 years (median age 54 years, 55% women) were included in the analysis. Both higher IL-6 and TNF-α at baseline predicted poorer performance in VF and WLL at 10-year follow-up (VF: IL-6 β: -1.14, p = 0.003, TNF-α β: -1.78, p = 0.008; WLL: IL-6 β: -0.61, p = 0.007, TNF-α β: -0.86, p = 0.03). Elevated IL-6 also predicted a greater decline in VF and WLL after a 10-year follow-up (VF: β: -0.81, p = 0.01; WLL: β: -0.53, p = 0.008). Baseline TNF-α did not predict cognitive decline, and hs-CRP did not predict cognitive performance or decline after 10-years. DISCUSSION: Our results suggest that low-grade inflammation in midlife is an independent risk factor for poorer cognitive performance later in life. Of the studied markers, IL-6 and TNF-α seem to be stronger predictors for cognitive performance and decline than hs-CRP.
引用
- Kipinoinen T, Toppala S, Rinne JO, et al. Association of Midlife Inflammatory Markers With Cognitive Performance at 10-Year Follow-up. Neurology. 2022. PMID: 36195448. doi:10.1212/WNL.0000000000201116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。